TXNRD1 and glioblastoma: Recently, thioredoxin reductase 1 (TrxR1) has been identified as a new disulfidptosis suppresser, and the inhibition of TrxR1 effectively sensitizes glucose-starved glioblastoma cells to disulfidptosis, highlighting the potential of targeting TrxR1 and disulfidptosis regulation as a novel therapeutic strategy in glioblastoma 22.